Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Saori MishimaYoichi NaitoKiwamu AkagiNaomi HayashiAkira HirasawaTomoro HishikiAtaru IgarashiMasafumi IkedaShigenori KadowakiHiroaki KajiyamaMotohiro KatoHirotsugu KenmotsuYasuhiro KoderaKeigo KomineTakafumi KoyamaOsamu MaedaMitsuru MiyachiHiroshi NishiharaHiroyuki NishiyamaShouichi OhgaWataru OkamotoEiji OkiShigeru OnoMasashi SanadaIkuo SekineTadao TakanoKayoko TaoKeita TerashimaKatsuya TsuchiharaYasushi YatabeTakayuki YoshinoEishi BabaPublished in: International journal of clinical oncology (2023)
In this guideline, the committee proposed eight recommendations for performing MMR testing properly to select patients who are likely to benefit from immunotherapy.